B7-H3 and its role in antitumor immunity

Clinical and Developmental Immunology

Volumn 2010, Issue , 2010, Pages

  Kleeff, Jörg ^a   Loos, Martin ^a   Hedderich, Dennis M ^a   Friess, Helmut ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; B7 H3 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; LYMPHOCYTE ANTIGEN; MEMBRANE PROTEIN; PROGRAMMED DEATH 1 RECEPTOR ANTIBODY; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG; CD276 PROTEIN, HUMAN; CYTOKINE; IMMUNOGLOBULIN RECEPTOR; LEUKOCYTE ANTIGEN; TUMOR MARKER;

ANTIGEN EXPRESSION; ANTIGEN STRUCTURE; ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER IMMUNOTHERAPY; CD8+ T LYMPHOCYTE; CLEAR CELL CARCINOMA; COLON CANCER; COLORECTAL CARCINOMA; HUMAN; IMMUNOGENICITY; KIDNEY CARCINOMA; LUNG NON SMALL CELL CANCER; LYMPHOMA; MELANOMA; METASTASIS; NATURAL KILLER CELL; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; REGULATORY MECHANISM; REVIEW; SUBCUTANEOUS TISSUE TUMOR; T LYMPHOCYTE; TUMOR IMMUNITY; BIOSYNTHESIS; FEMALE; GENETICS; IMMUNOLOGY; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; MALE; METABOLISM; NEOPLASM; PATHOPHYSIOLOGY; SURVIVAL; TUMOR ASSOCIATED LEUKOCYTE;

ANTIGENS, CD; CYTOKINES; FEMALE; HUMANS; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; NEOPLASMS; RECEPTORS, IMMUNOLOGIC; SURVIVAL ANALYSIS; T-LYMPHOCYTES; TUMOR MARKERS, BIOLOGICAL;

EID: 79251582822     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2010/683875     Document Type: Review

References (55)

1. Abbas A. K., The control of T cell activation vs. tolerance Autoimmunity Reviews 2003 2 3 115 118
2. Chen L., Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity Nature Reviews Immunology 2004 4 5 336 347
3. Greenwald R. J., Freeman G. J., Sharpe A. H., The B7 family revisited Annual Review of Immunology 2005 23 515 548
4. Loos M., Giese N. A., Kleeff J., Giese T., Gaida M. M., Bergmann F., Laschinger M., W.Bchler M., Friess H., Clinical significance and regulation of the costimulatory molecule B7-H1 in pancreatic cancer Cancer Letters 2008 268 1 98 109
5. Konishi J., Yamazaki K., Azuma M., Kinoshita I., Dosaka-Akita H., Nishimura M., B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression Clinical Cancer Research 2004 10 15 5094 5100
6. Liu Y., Zeng B., Zhang Z., Zhang Y., Yang R., B7-H1 on myeloid-derived suppressor cells in immune suppression by a mouse model of ovarian cancer Clinical Immunology 2008 129 3 471 481
7. Ghebeh H., Mohammed S., Al-Omair A., Qattan A., Lehe C., Al-Qudaihi G., Elkum N., Alshabanah M., Amer S. B., Tulbah A., Ajarim D., Al-Tweigeri T., Dermime S. D., The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors Neoplasia 2006 8 3 190 198
8. Thompson R. H., Gillett M. D., Cheville J. C., Lohse C. M., Dong H., Webster W. S., Krejci K. G., Lobo J. R., Sengupta S., Chen L., Zincke H., Blute M. L., Strome S. E., Leibovich B. C., Kwon E. D., Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target Proceedings of the National Academy of Sciences of the United States of America 2004 101 49 17174 17179
9. Small E. J., Tchekmedyian N. S., Rini B. I., Fong L., Lowy I., Allison J. P., A pilot trial of CTLA-4 blockade with human anti-CTLA-4 in patients with hormone-refractory prostate cancer Clinical Cancer Research 2007 13 6 1810 1815
10. Kwon E. D., Foster B. A., Hurwitz A. A., Madias C., Allison J. P., Greenberg N. M., Burg M. B., Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy Proceedings of the National Academy of Sciences of the United States of America 1999 96 26 15074 15079
11. Theoret M. R., Arlen P. M., Pazdur M., Dahut W. L., Schlom J., Gulley J. L., Phase I trial of an enhanced prostate-specific antigen-based vaccine and anti-CTLA-4 antibody in patients with metastatic androgen-independent prostate cancer Clinical Genitourinary Cancer 2007 5 5 347 350
12. Liakou C. I., Kamat A., Tang D. N., Chen H., Sun J., Troncoso P., Logothetis C., Sharma P., CTLA-4 blockade increases IFN -producing CD4+ICOS hi cells to shift the ratio of effector to regulatory T cells in cancer patients Proceedings of the National Academy of Sciences of the United States of America 2008 105 39 14987 14992
13. Thompson R. H., Allison J. P., Kwon E. D., Anti-cytotoxic T lymphocyte antigen-4 (CTLA-4) immunotherapy for the treatment of prostate cancer Urologic Oncology 2006 24 5 442 447
14. Blansfield J. A., Beck K. E., Tran K., Yang J. C., Hughes M. S., Kammula U. S., Royal R. E., Topalian S. L., Haworth L. R., Levy C., Rosenberg S. A., Sherry R. M., Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer Journal of Immunotherapy 2005 28 6 593 598
15. Yuan J., Gnjatic S., Li H., Powel S., Gallardo H. F., Ritter E., Ku G. Y., Jungbluth A. A., Segal N. H., Rasalan T. S., Manukian G., Xu Y., Roman R.-A., Terzulli S. L., Heywood M., Pogoriler E., Ritter G., Old L. J., Allison J. P., Wolchok J. D., CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit Proceedings of the National Academy of Sciences of the United States of America 2008 105 51 20410 20415
16. O'Mahony D., Morris J. C., Quinn C., Gao W., Wilson W. H., Gause B., Pittaluga S., Neelapu S., Brown M., Fleisher T. A., Gulley J. L., Schlom J., Nussenblatt R., Albert P., Davis T. A., Lowy I., Petrus M., Waldmann T. A., Janik J. E., A pilot study of CTLA-4 blockade after cancer vaccine failure in patients with advanced malignancy Clinical Cancer Research 2007 13 3 958 964
17. Ansell S. M., Hurvitz S. A., Koenig P. A., LaPlant B. R., Kabat B. F., Fernando D., Habermann T. M., Inwards D. J., Verma M., Yamada R., Erlichman C., Lowy I., Timmerman J. M., Phase I study of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with relapsed and refractory B-cell non-Hodgkin lymphoma Clinical Cancer Research 2009 15 20 6446 6453
18. Chapoval A. I., Ni J., Lau J. S., Wilcox R. A., Flies D. B., Liu D., Dong H., Sica G. L., Zhu G., Tamada K., Chen L., B7-H3: a costimulatory molecule for T cell activation and IFN- production Nature Immunology 2001 2 3 269 274
19. Castriconi R., Dondero A., Augugliaro R., Cantoni C., Carnemolla B., Sementa A. R., Negri F., Conte R., Corrias M. V., Moretta L., Moretta A., Bottino C., Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis Proceedings of the National Academy of Sciences of the United States of America 2004 101 34 12640 12645
20. Steinberger P., Majdic O., Derdak S. V., Pfistershammer K., Kirchberger S., Klauser C., Zlabinger G., Pickl W. F., Stckl J., Knapp W., Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains Journal of Immunology 2004 172 4 2352 2359
21. Hashiguchi M., Kobori H., Ritprajak P., Kamimura Y., Kozono H., Azuma M., Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses Proceedings of the National Academy of Sciences of the United States of America 2008 105 30 10495 10500
22. Klesney-Tait J., Turnbull I. R., Colonna M., The TREM receptor family and signal integration Nature Immunology 2006 7 12 1266 1273
23. Leitner J., Klauser C., Pickl W. F., Stkl J., Majdic O., Bardet A. F., Kreil D. P., Dong C., Yamazaki T., Zlabinger G., Pfistershammer K., Steinberger P., B7-H3 is a potent inhibitor of human T-cell activation: no evidence for B7-H3 and TREML2 interaction European Journal of Immunology 2009 39 7 1754 1764
24. Sun Y., Wang Y., Zhao J., Gu M., Giscombe R., Lefvert A. K., Wang X., B7-H3 and B7-H4 expression in non-small-cell lung cancer Lung Cancer 2006 53 2 143 151
25. Loos M., Hedderich D. M., Ottenhausen M., Giese N. A., Laschinger M., Esposito I., Kleeff J., Friess H., Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancer BMC Cancer 2009 9, article 463
26. Wu X.-P., Jiang J.-T., Tan M., Zhu Y.-B., Ji M., Xu K.-F., Zhao J.-M., Zhang G.-B., Zhang X.-G., Relationship between co-stimulatory molecue B7-H3 expression and gastric carcinoma histology and prognosis World Journal of Gastroenterology 2006 12 3 457 459
27. Zang X., Sullivan P. S., Soslow R. A., Waitz R., Reuter V. E., Wilton A., Thaler H. T., Arul M., Slovin S. F., Wei J., Spriggs D. R., Dupont J., Allison J. P., Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas Modern Pathology 2010 23 8 1104 1112
28. Crispen P. L., Sheinin Y., Roth T. J., Lohse C. M., Kuntz S. M., Frigola X., Houston Thompson R., Boorjian S. A., Dong H., Leibovich B. C., Blute M. L., Kwon E. D., Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma Clinical Cancer Research 2008 14 16 5150 5157
29. Sun J., Chen L. -J., Zhang G. -B., Jiang J. -T., Zhu M., Tan Y., Wang H. -T., Lu B. -F., Zhang X. -G., Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma Cancer Immunology, Immunotherapy 2010 59 8 1163 1171
30. Boorjian S. A., Sheinin Y., Crispen P. L., Farmer S. A., Lohse C. M., Kuntz S. M., Leibovich B. C., Kwon E. D., Frank I., T-Cell coregulatory molecule expression in urothelial cell carcinoma: clinicopathologic correlations and association with survival Clinical Cancer Research 2008 14 15 4800 4808
31. Roth T. J., Sheinin Y., Lohse C. M., Kuntz S. M., Frigola X., Inman B. A., Krambeck A. E., Mckenney M. E., Karnes R. J., Blute M. L., Cheville J. C., Sebo T. J., Kwon E. D., B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy Cancer Research 2007 67 16 7893 7900
32. Wang L., Fraser C. C., Kikly K., Wells A. D., Han R., Coyle A. J., Chen L., Hancock W. W., B7-H3 promotes acute and chronic allograft rejection European Journal of Immunology 2005 35 2 428 438
33. Nagashima O., Harada N., Usui Y., Yamazaki T., Yagita H., Okumura K., Takahashi K., Akiba H., B7-H3 contributes to the development of pathogenic Th2 cells in a murine model of asthma Journal of Immunology 2008 181 6 4062 4071
34. Luo L., Chapoval A. I., Flies D. B., Zhu G., Hirano F., Wang S., Lau J. S., Dong H., Tamada K., Flies A. S., Liu Y., Chen L., B7-H3 enhances tumor immunity in vivo by costimulating rapid clonal expansion of antigen-specific CD8+ cytolytic T cells Journal of Immunology 2004 173 9 5445 5450
35. Sun X., Vale M., Leung E., Kanwar J. R., Gupta R., Krissansen G. W., Mouse B7-H3 induces antitumor immunity Gene Therapy 2003 10 20 1728 1734
36. Lupu C. M., Eisenbach C., Lupu A. D., Kuefner M. A., Hoyler B., Stremmel W., Encke J., Adenoviral B7-H3 therapy induces tumor specific immune responses and reduces secondary metastasis in a murine model of colon cancer Oncology reports 2007 18 3 745 748
37. Ma L., Luo L., Qiao H., Dong X., Pan S., Jiang H., Krissansen G. W., Sun X., Complete eradication of hepatocellular carcinomas by combined vasostatin gene therapy and B7H3-mediated immunotherapy Journal of Hepatology 2007 46 1 98 106
38. Suh W.-K., Gajewska B. U., Okada H., Gronski M. A., Bertram E. M., Dawicki W., Duncan G. S., Bukczynski J., Plyte S., Elia A., Wakeham A., Itie A., Chung S., Da Costa J., Arya S., Horan T., Campbell P., Gaida K., Ohashi P. S., Watts T. H., Yoshinaga S. K., Bray M. R., Jordana M., Mak T. W., The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses Nature Immunology 2003 4 9 899 906
39. Prasad D. V. R., Nguyen T., Li Z., Yang Y., Duong J., Wang Y., Dong C., Murine B7-H3 is a negative regulator of T cells Journal of Immunology 2004 173 4 2500 2506
40. Fukushima A., Sumi T., Fukuda K., Kumagai N., Nishida T., Yamazaki T., Akiba H., Okumura K., Yagita H., Ueno H., B7-H3 regulates the development of experimental allergic conjunctivitis in mice Immunology Letters 2007 113 1 52 57
41. Mahnke K., Ring S., Johnson T. S., Schallenberg S., Schnfeld K., Storn V., Bedke T., Enk A. H., Induction of immunosuppressive functions of dendritic cells in vivo by CD4+CD25+ regulatory T cells: role of B7-H3 expression and antigen presentation European Journal of Immunology 2007 37 8 2117 2126
42. Zhang G., Xu Y., Lu X., Huang H., Zhou Y., Lu B., Zhang X., Diagnosis value of serum B7-H3 expression in non-small cell lung cancer Lung Cancer 2009 66 2 245 249
43. Zang X., Thompson R. H., Al-Ahmadie H. A., Serio A. M., Reuter V. E., Eastham J. A., Scardino P. T., Sharma P., Allison J. P., B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome Proceedings of the National Academy of Sciences of the United States of America 2007 104 49 19458 19463
44. Boorjian S. A., Sheinin Y., Crispen P. L., Lohse C. M., Leibovich B. C., Kwon E. D., T-cell co-regulatory molecule expression in renal angiomyolipoma and pulmonary lymphangioleiomyomatosis Urology 2009 74 6 1359 1364
45. Gregorio A., Corrias M. V., Castriconi R., Dondero A., Mosconi M., Gambini C., Moretta A., Moretta L., Bottino C., Small round blue cell tumours: diagnostic and prognostic usefulness of the expression of B7-H3 surface molecule Histopathology 2008 53 1 73 80
46. Parker A. S., Heckman M. G., Sheinin Y., Wu K. J., Hilton T. W., Diehl N. N., Pisansky T. M., Schild S. E., Kwon E. D., Buskirk S. J., Evaluation of B7-H3 expression as a biomarker of biochemical recurrence after salvage radiation therapy for recurrent prostate cancer. International Journal of Radiation Oncology, Biology, Physics. In press
47. Yamato I., Sho M., Nomi T., Akahori T., Shimada K., Hotta K., Kanehiro H., Konishi N., Yagita H., Nakajima Y., Clinical importance of B7-H3 expression in human pancreatic cancer British Journal of Cancer 2009 101 10 1709 1716
48. Tirapu I., Huarte E., Guiducci C., Anna A., Zaratiegui M., Murillo O., Gonzalez A., Berasain C., Berraondo P., Fortes P., Prieto J., Colombo M. P., Chen L., Melero I., Low surface expression of B7-1 (CD80) is an immunoescape mechanism of colon carcinoma Cancer Research 2006 66 4 2442 2450
49. Yi K. H., Chen L., Fine tuning the immune response through B7-H3 and B7-H4 Immunological Reviews 2009 229 1 145 151
50. Sun T., Hu Z., Shen H., Lin D., Genetic polymorphisms in cytotoxic T-lymphocyte antigen 4 and cancer: the dialectical nature of subtle human immune dysregulation Cancer Research 2009 69 15 6011 6014
51. Dewan M. Z., Galloway A. E., Kawashima N., Dewyngaert J. K., Babb J. S., Formenti S. C., Demaria S., Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody Clinical Cancer Research 2009 15 17 5379 5388
52. Maker A. V., Phan G. Q., Attia P., Yang J. C., Sherry R. M., Topalian S. L., Kammula U. S., Royal R. E., Haworth L. R., Levy C., Kleiner D., Mavroukakis S. A., Yellin M., Rosenberg S. A., Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II study Annals of Surgical Oncology 2005 12 12 1005 1016
53. Hodi F. S., Mihm M. C., Soiffer R. J., Haluska F. G., Butler M., Seiden M. V., Davis T., Henry-Spires R., MacRae S., Willman A., Padera R., Jaklitsch M. T., Shankar S., Chen T. C., Korman A., Allison J. P., Dranoff G., Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients Proceedings of the National Academy of Sciences of the United States of America 2003 100 8 4712 4717
54. van der Vliet H. J. J., Koon H. B., Yue S. C., Uzunparmak B., Seery V., Gavin M. A., Rudensky A. Y., Atkins M. B., Balk S. P., Exley M. A., Effects of the administration of high-dose interleukin-2 on immunoregulatory cell subsets in patients with advanced melanoma and renal cell cancer Clinical Cancer Research 2007 13 7 2100 2108
55. Brahmer J. R., Drake C. G., Wollner I., Powderly J. D., Picus J., Sharfman W. H., Stankevich E., Pons A., Salay T. M., McMiller T. L., Gilson M. M., Wang C., Selby M., Taube J. M., Anders R., Chen L., Korman A. J., Pardoll D. M., Lowy I., Topalian S. L., Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates Journal of Clinical Oncology 2010 28 19 3167 3175